MULHOUSE, France--(BUSINESS WIRE)--CellProthera has been awarded the 2014 UBISTART prize, under the aegis of UBIFRANCE and the Galien Foundation based in New York. This initiative rewards innovative French start-ups for making major advances in the field of life sciences.
An international panel, consisting of 7 eminent pharmaceutical and scientific experts, chose CellProthera from among 9 projects for its revolutionary treatment of myocardial infarction. All those projects were outstanding and selected from more than 200 application entries. This UBISTART price was officially awarded to Professor Philippe Hénon and Jean-Claude Jelsch, Chairman and CEO of CellProthera respectively, during the 2014 Galien award ceremony held in Monaco on 4 December.
Help employers find you! Check out all the jobs and post your resume.
